Article
Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR+/- and LDLR-/-) Yucatan Miniature Pigs.
Arteriosclerosis, thrombosis, and vascular biology - 1 May 2018
Burke Amy C, Telford Dawn E, Sutherland Brian G, Edwards Jane Y, Sawyez Cynthia G, Barrett P Hugh R, Newton Roger S, Pickering J Geoffrey, Huff Murray W
Abstract excerpt
OBJECTIVE: Bempedoic acid (BemA; ETC-1002) is a novel drug that targets hepatic ATP-citrate lyase to reduce cholesterol biosynthesis. In phase 2 studies, BemA lowers elevated low-density lipoprotein cholesterol (LDL-C) in hypercholesterolemic patients. In the present study, we tested the ability of BemA to decrease plasma cholesterol and LDL-C and attenuate atherosclerosis in a large animal model of familial...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.